Welcome to Lux Recommends #215, this week’s edition of what we at Lux are reading and thinking about (want to receive this by email? Sign up here).
Highlights from studies on the gut microbiome: “Researchers strive to understand how microbes affect health and disease. “— Friend of Lux Guy Perelmuter
Human Body-on-Chip platform enables in vitro prediction of drug behaviors in humans: “Fluidically-linked systems of multiple human Organ Chips that quantitatively predict drug pharmacokinetics may offer alternatives to some animal tests” — Ian
Does a Famous Bay Area Pizza Help Induce Labor? Expectant Moms Think So: “Doctors say there’s no magical food that can cause contractions to start, but that hasn’t stopped parents-to-be from lining up for the ‘Prego’” — Adam K
Step aside CRISPR, RNA editing is taking off: “Making changes to the molecular messengers that create proteins might offer flexible therapies for cancer, pain or high cholesterol, in addition to genetic disorders.”— Ian
There’s a Cancer Treatment That Gives People ‘Night Vision’, And We Finally Know Why — Lux Recommends reader Greg Greenberg
And an article by Tim Lu, CEO of Lux portfolio company Senti Biosciences: Gene Circuits Empower Next-Generation Cell and Gene Therapies
Want to receive this by email? Sign up here.
And have a suggestion? Let us know.